Five next-generation therapeutics reshaping longevity
"Aging is modular — combinations targeting orthogonal hallmarks define next-gen geroprotection"

"Aging is modular — combinations targeting orthogonal hallmarks define next-gen geroprotection"

The field of men's longevity medicine in 2026 is finally catching up to what precision medicine has always known:the male body requires the same level of individualized hormonal intelligence as the female body. Comprehensive testosterone optimization
Elamipretide — the first FDA-approved mitochondrial peptide — works by stepping inside the mitochondria and repairing the actual structure of the inner membrane. This is not symptom management. This is cellular repair at the source of aging.

The FDA has officially dismantled the single biggest obstacle to women's hormone health in the last quarter century. The black box warnings that caused a generation of physicians to deny midlife women hormone therapy.